STONEHOUSE JON P reported 1 transaction at BIOCRYST PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/23/2025ACC: 0000882796-25-000045
Director
Since Feb 2026
-61.79K
Net shares
Net seller
$457.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
61.79K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−61.79K
Price / share
$7.41
Trade value
$457.89K
% of position
4.5%
12/19/2025
1.39M→1.32M
Total
Net shares
−61.79K
Net value
-$457.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | F · Tax Withholding | −61.79K | $7.41 | $457.89K | 4.5% | 1.39M | 1.32M |
| Total | −61.79K | -$457.89K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned40K
Common Stock
IndirectShares owned40K
Total
80K indirect80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40K | Indirect |
| Common Stock | 40K | Indirect |
| Total | 80K | 80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported